Total Payments
$1,115
2024 Payments
$275.00
Companies
9
Transactions
18
Medicare Patients
1,829
Medicare Billing
$308,406
Payment Breakdown by Category
Food & Beverage$1,099 (98.6%)
Education$16.14 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,099 | 12 | 98.6% |
| Education | $16.14 | 6 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $250.00 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $237.14 | 2 | $0 (2023) |
| Amgen Inc. | $150.00 | 1 | $0 (2024) |
| Novo Nordisk Inc | $125.00 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $120.00 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $105.74 | 1 | $0 (2018) |
| SCPHARMACEUTICALS INC. | $68.00 | 1 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $46.23 | 8 | $0 (2017) |
| PFIZER INC. | $13.23 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $275.00 | 2 | Amgen Inc. ($150.00) |
| 2023 | $438.00 | 4 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2022 | $237.14 | 2 | GlaxoSmithKline, LLC. ($125.00) |
| 2018 | $105.74 | 1 | Novartis Pharmaceuticals Corporation ($105.74) |
| 2017 | $59.46 | 9 | Sunovion Pharmaceuticals Inc. ($46.23) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Cardiology | ||||||
| 02/21/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 12/04/2023 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $68.00 | General |
| Category: Cardiology | ||||||
| 10/25/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 08/02/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $120.00 | General |
| Category: Cardiovascular | ||||||
| 05/03/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/09/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 07/13/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $112.14 | General |
| Category: Respiratory | ||||||
| 10/24/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $105.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/03/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2017 | PFIZER INC. | VIAGRA (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 08/23/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 06/28/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2017 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: CNS | ||||||
| 06/08/2017 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $12.71 | General |
| Category: CNS | ||||||
| 05/09/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
| 04/12/2017 | Sunovion Pharmaceuticals Inc. | UTIBRON (Drug) | Education | In-kind items and services | $2.69 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 399 | 906 | $110,781 | $59,240 |
| 2022 | 11 | 469 | 1,163 | $134,803 | $71,662 |
| 2021 | 9 | 430 | 1,308 | $151,977 | $80,854 |
| 2020 | 13 | 531 | 1,538 | $178,584 | $96,650 |
Total Patients
1,829
Total Services
4,915
Medicare Billing
$308,406
Procedure Codes
39
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 112 | 514 | $55,486 | $31,120 | 56.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 108 | 126 | $25,200 | $11,981 | 47.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 118 | 135 | $14,460 | $8,276 | 57.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 102 | $11,650 | $5,526 | 47.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 16 | 16 | $3,520 | $1,960 | 55.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 13 | $465.00 | $376.98 | 81.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 106 | 609 | $65,163 | $33,369 | 51.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 88 | 97 | $19,400 | $9,783 | 50.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 159 | $17,013 | $9,593 | 56.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 109 | 121 | $12,705 | $6,596 | 51.9% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 14 | 57 | $6,156 | $3,921 | 63.7% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 24 | 24 | $5,640 | $3,154 | 55.9% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Office | 2022 | 14 | 18 | $2,790 | $1,702 | 61.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 23 | 23 | $2,415 | $1,237 | 51.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 16 | 16 | $1,200 | $1,124 | 93.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 21 | 22 | $638.00 | $615.47 | 96.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 14 | 17 | $1,683 | $566.43 | 33.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 105 | 756 | $80,892 | $42,423 | 52.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 94 | 111 | $22,200 | $11,378 | 51.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 51 | 164 | $17,548 | $9,397 | 53.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 97 | 114 | $11,970 | $6,351 | 53.1% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 15 | 90 | $9,720 | $5,976 | 61.5% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 22 | 23 | $5,405 | $3,282 | 60.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 21 | 22 | $2,310 | $1,239 | 53.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 13 | 16 | $1,584 | $613.05 | 38.7% |
About Dr. Kandasamy Umapathy, M.D
Dr. Kandasamy Umapathy, M.D is a Internal Medicine healthcare provider based in Bedford, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1316947708.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kandasamy Umapathy, M.D has received a total of $1,115 in payments from pharmaceutical and medical device companies, with $275.00 received in 2024. These payments were reported across 18 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,099).
As a Medicare-enrolled provider, Umapathy has provided services to 1,829 Medicare beneficiaries, totaling 4,915 services with total Medicare billing of $308,406. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Bedford, OH
- Active Since 07/28/2005
- Last Updated 04/26/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1316947708
Products in Payments
- Repatha (Biological) $150.00
- AREXVY (Drug) $125.00
- FARXIGA (Drug) $125.00
- ELIQUIS (Drug) $120.00
- BREZTRI (Drug) $112.14
- ENTRESTO (Drug) $105.74
- FUROSCIX (Drug) $68.00
- APTIOM (Drug) $30.09
- UTIBRON (Drug) $16.14
- VIAGRA (Drug) $13.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bedford
Dr. Michael Delaughter, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $1.7M
Internal Medicine $1.7M
Scott Greenberg, Md, MD
Internal Medicine — Payments: $171,246
Internal Medicine $171,246
Dr. Venkatesan Vidi, M.d., M.p.h, M.D., M.P.H
Internal Medicine — Payments: $17,343
Internal Medicine $17,343
Dr. Elmer Smith, Md, MD
Internal Medicine — Payments: $17,311
Internal Medicine $17,311
Paul Kim, Md, MD
Internal Medicine — Payments: $15,775
Internal Medicine $15,775
Alisa Thamwiwat, M.d, M.D
Internal Medicine — Payments: $13,867
Internal Medicine $13,867